Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program

Yang Chen, Valerie S. LeBleu, Julienne L. Carstens, Hikaru Sugimoto, Xiaofeng Zheng, Shruti Malasi, Dieter Saur, Raghu Kalluri

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Abstract

Epithelial-to-mesenchymal transition (EMT) is a recognized eukaryotic cell differentiation program that is also observed in association with invasive tumors. Partial EMT program in carcinomas imparts cancer cells with mesenchymal-like features and is proposed as essential for metastasis. Precise determination of the frequency of partial EMT program in cancer cells in tumors and its functional role in metastases needs unraveling. Here, we employed mesenchymal cell reporter mice driven by αSMA-Cre and Fsp1-Cre with genetically engineered mice that develop spontaneous pancreatic ductal adenocarcinoma (PDAC) to monitor partial EMT program. Both αSMA- and Fsp1-Cre-mediated partial EMT programs were observed in the primary tumors. The established metastases were primarily composed of cancer cells without evidence for a partial EMT program, as assessed by our fate mapping approach. In contrast, metastatic cancer cells exhibiting a partial EMT program were restricted to isolated single cancer cells or micrometastases (3–5 cancer cells). Collectively, our studies identify large metastatic nodules with preserved epithelial phenotype and potentially unravel a novel metastasis program in PDAC.

Original languageEnglish (US)
Article numbere9085
JournalEMBO Molecular Medicine
Volume10
Issue number10
DOIs
StatePublished - Oct 2018

Keywords

  • dual-recombinase system
  • metastasis
  • micrometastasis
  • pancreatic ductal adenocarcinoma
  • partial epithelial-to-mesenchymal transition

ASJC Scopus subject areas

  • Molecular Medicine

Fingerprint

Dive into the research topics of 'Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program'. Together they form a unique fingerprint.

Cite this